PISCES: a horoscope for first-line targeted therapy of metastatic renal cell carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 32 ·No. 33 ·2014-11-20 ·Pages 3783

Sun M, Larcher A, Schiffmann J, Karakiewicz PI

Abstract

暂无摘要

MeSH Terms

Antineoplastic Agents/therapeutic use Carcinoma, Renal Cell/drug therapy Female Humans Indoles/adverse effects Kidney Neoplasms/drug therapy Male Patient Preference Pyrimidines/adverse effects Pyrroles/adverse effects Sulfonamides/adverse effects

Chemicals

Antineoplastic Agents Indoles Pyrimidines Pyrroles Sulfonamides

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Sun Maxine

University of Montreal Health Center, Montreal, Quebec, Canada mcw.sun@umontreal.ca.

Larcher Alessandro

University of Montreal Health Center, Montreal, Quebec, Canada.

Schiffmann Jonas

University of Montreal Health Center, Montreal, Quebec, Canada.

Karakiewicz Pierre I

University of Montreal Health Center, Montreal, Quebec, Canada.

Article Info

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abbr.

J Clin Oncol

ISSN

1527-7755

DOI

10.1200/JCO.2014.57.4673

mcw.sun@umontreal.ca

Published

2014-11-20

Epub

2014-00-29

Pages

3783

Language

English

Region

United States

NLM ID

8309333

Subset

Corrections

CommentOn

PMID: 24687826

CommentIn

PMID: 25267752

External Links

PubMed source DOI: 10.1200/JCO.2014.57.4673 View journal details

Analysis Services

PISCES: a horoscope for first-line targeted therapy of metastatic renal cell carcinoma.

Contact

WeChat Official Account